MD95C2 - Способ получения человеческого эритропоэтина - Google Patents

Способ получения человеческого эритропоэтина

Info

Publication number
MD95C2
MD95C2 MD94-0104A MD940104A MD95C2 MD 95 C2 MD95 C2 MD 95C2 MD 940104 A MD940104 A MD 940104A MD 95 C2 MD95 C2 MD 95C2
Authority
MD
Moldova
Prior art keywords
preparation
human
erythropoietine
recombinate
elimination
Prior art date
Application number
MD94-0104A
Other languages
English (en)
Romanian (ro)
Other versions
MD95B1 (ro
Inventor
Kenneth Jacobs
Edward Fritsch
Original Assignee
Genetics Institute, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24783958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD95(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US1985/002405 external-priority patent/WO1986003520A1/en
Priority claimed from SU864028136A external-priority patent/SU1672930A3/ru
Application filed by Genetics Institute, Inc. filed Critical Genetics Institute, Inc.
Publication of MD95B1 publication Critical patent/MD95B1/xx
Publication of MD95C2 publication Critical patent/MD95C2/ru

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Изобретение относится к генетической инженерии и касается получения рекомбинантый плазмидных ДНК, содержащих гены эритропоэтина, которые обеспечивают высокие уровки экспрессиии указанных генов и получения in vitro активного человеческого эритропоэтина. Целью изобретения является повышение активности эритропоэтина. Способ состоит в том, что осуществляют получение геномного ДНК клона эритропоэтина человека гибридацией с зондами и его выделение, конструирование рекомбинантных плазмидных ДНК, кодирующих ЭПО человека с последующей трансформацией полученными ДНК штаммов клеток млекопитающих (например cos I), выделением и очисткой целового продукта.
MD94-0104A 1985-01-22 1994-02-09 Способ получения человеческого эритропоэтина MD95C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69325885A 1985-01-22 1985-01-22
PCT/US1985/002405 WO1986003520A1 (en) 1984-12-04 1985-12-03 Method for the production of erythropoietin
SU864028136A SU1672930A3 (ru) 1985-01-03 1986-08-01 Способ получени кДНК-клонов, кодирующих человеческий эритропоэтин
SU874203324A RU1801118C (ru) 1985-01-22 1987-09-09 Способ получени человеческого эритропоэтина

Publications (2)

Publication Number Publication Date
MD95B1 MD95B1 (ro) 1994-11-30
MD95C2 true MD95C2 (ru) 1995-03-31

Family

ID=24783958

Family Applications (1)

Application Number Title Priority Date Filing Date
MD94-0104A MD95C2 (ru) 1985-01-22 1994-02-09 Способ получения человеческого эритропоэтина

Country Status (4)

Country Link
DD (1) DD279687A5 (ru)
MD (1) MD95C2 (ru)
RU (1) RU1801118C (ru)
UA (1) UA19039A (ru)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Brevet US nr. 4377513, Int. cl. A 61 K 37/24, 1983. *

Also Published As

Publication number Publication date
MD95B1 (ro) 1994-11-30
RU1801118C (ru) 1993-03-07
UA19039A (ru) 1997-12-25
DD279687A5 (de) 1990-06-13

Similar Documents

Publication Publication Date Title
IL72643A (en) Gene encoding an analog of human interleukin-ii which substantially retains the biological activity of natural human interleukin-ii,microorganism expression vector containing the gene,microorganisms transformed by the vector and the human interleukin-ii analog produced by the microorganisms
IL61982A (en) Genetically engineered microorganisms for massive production of amyloytic enzymes and process for preparing same using the corresponding recombinant dnas containing amylase coding genes
IT8721107A0 (it) Dell'anidride carbonica. reattore fotobiologico con sistema perfezionato di alimentazione
WO1996019568A3 (en) Stabilized ribozyme analogs
IL74909A (en) Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
NZ243500A (en) Nucleic acid encoding dihydrokaempferol hydroxylating enzyme (dhk) and its use in producing transgenic flowering plants
PT84397A (en) Process for preparing anticalculus dentifrices containing pyrophosphate and tripolyphosphate
IL123833A0 (en) Vector and method of use for nucleic acid delivery to non-dividing cells
ZW2485A1 (en) Cloning of dna for protozoal antigens
DE3861642D1 (de) Katalysator zur wasserstoffbehandlung von kohlenwasserstoffen und methode zu dessen herstellung.
DE69635978D1 (de) Der hefe die flockungsfähigkeit verleihendes gen und genprodukt
ZA883529B (en) Stable human cell lines expressing an indicator gene product under virus-specific genetic controls
DE3787998D1 (de) ART-Nukleotidsegmente, -Vektoren, -Zellinien, Verfahren zur Herstellung und Verwendung.
EP0054330A3 (en) Dna sequences encoding the various allelic forms of mature thaumatin, and cloning vehicles comprising said dna's and their use in transforming microorganisms
AR240549A1 (es) Procedimiento para la realizacion de la oxidacion en elciclo para la preparacion de peroxido de hidrogeno segun el procedimiento de la antraquinona
EP0178443A3 (en) Soaps and shampoos containing bioemulsifiers
Schei et al. A stoichiometric model of the ferrosilicon process
MD95C2 (ru) Способ получения человеческого эритропоэтина
CS274677B2 (en) Method of 7-piperazino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxyl acid's derivatives production
DE3678702D1 (de) Antitumorprotein-gen von streptococcus pyogenes su, plasmide, die das gen enthalten, transformantenzellen, die die plasmide beherbergen, und verfahren zur herstellung des antitumorproteins.
DE3485923D1 (de) Dna-gen, verfahren zu seiner herstellung und dieses gen enthaltendes plasmid.
AU2791289A (en) Catalytic recombination of evolved oxygen in galvanic cells
HUT47976A (en) Process for producing recombinant expression dna vectors encoding isopenicillin-n-synthetase enzyme of aspergillus nidulans, as well as dna molecules
AU1164588A (en) Nucleotide analogs, their production and use
AU3905893A (en) Plant resistant to two or more viruses and preparation thereof

Legal Events

Date Code Title Description
FG4A Patent for invention issued
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20051202